Application of 99822-23-8, Chemistry is the experimental science by definition. We want to make observations to prove hypothesis. For this purpose, we perform experiments in the lab. 99822-23-8, Name is 5-Fluorobenzo[d]isoxazol-3(2H)-one, molecular formula is C7H4FNO2, introducing its new discovery.
CRYSTALLINE FORMS OF 4-(5-(4,7-DIMETHYLBENZOFURAN-2-YL)-1,2,4-OXADIAZOL-3-YL)BENZOIC ACID AND PROCESSES FOR THEIR PREPARATION
The present invention pertains generally to the field of therapeutic compounds, and more specifically to crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid (referred to herein as “BHBA-001”), which, inter alia, is a (selective) retinoic acid receptor beta (RARbeta) (e.g., RARbeta2) agonist. The present invention also pertains to pharmaceutical compositions comprising such crystalline forms, and the use of such crystalline forms and compositions, both in vitro and in vivo, to (selectively) activate RARbeta (e.g., RARbeta2), to cause or promote neurite development, neurite outgrowth, and/or neurite regeneration, and in the treatment of diseases and conditions that are mediated by RARbeta (e.g., RARbeta2), that are ameliorated by the activation of RARbeta (e.g., RARbeta2), etc., including, e.g., neurological injuries such as spinal cord injuries.
Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 99822-23-8
Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics